Effects of sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients.
Ryutaro MoritaShunichiro TsukamotoShota ObataTakayuki YamadaKazushi UnedaTatsuki UeharaMuhammad Ebad RehmanKengo AzushimaHiromichi WakuiKouichi TamuraPublished in: Diabetes, obesity & metabolism (2023)
Combination therapy with SGLT2-Is and MRAs was associated with lower albuminuria in patients with type 2 DM compared to monotherapy with SGLT2-Is or MRAs alone. This article is protected by copyright. All rights reserved.